Drug Shortage Report for INJECTABLE NALOXONE HYDROCHLORIDE

Last updated on 2021-09-08 History
Report ID 141977
Drug Identification Number 02455935
Brand name INJECTABLE NALOXONE HYDROCHLORIDE
Common or Proper name Naloxone Hydrochloride Injection
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) NALOXONE HYDROCHLORIDE
Strength(s) 0.4MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 1mL vial / fiole
ATC code V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-07-23
Estimated end date 2021-10-08
Actual end date 2021-09-07
Shortage status Resolved
Updated date 2021-09-08
Company comments High Demand on Market. On and Off Backorder.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2021-09-08 English Compare
v14 2021-09-07 French Compare
v13 2021-09-07 English Compare
v12 2021-09-01 French Compare
v11 2021-09-01 English Compare
v10 2021-08-03 French Compare
v9 2021-08-03 English Compare
v8 2021-07-29 French Compare
v7 2021-07-29 English Compare
v6 2021-07-29 English Compare
v5 2021-07-24 English Compare
v4 2021-07-19 French Compare
v3 2021-07-19 English Compare
v2 2021-07-07 French Compare
v1 2021-07-07 English Compare

Showing 1 to 15 of 15